Cargando…
Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity
A recently discovered bisubstrate inhibitor of Nicotinamide N-methyltransferase (NNMT) was found to be highly potent in biochemical assays with a single digit nanomolar IC(50) value but lacking in cellular activity. We, here, report a prodrug strategy designed to translate the observed potent bioche...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466754/ https://www.ncbi.nlm.nih.gov/pubmed/34572571 http://dx.doi.org/10.3390/biom11091357 |
_version_ | 1784573220663328768 |
---|---|
author | van Haren, Matthijs J. Gao, Yongzhi Buijs, Ned Campagna, Roberto Sartini, Davide Emanuelli, Monica Mateuszuk, Lukasz Kij, Agnieszka Chlopicki, Stefan Escudé Martinez de Castilla, Pol Schiffelers, Raymond Martin, Nathaniel I. |
author_facet | van Haren, Matthijs J. Gao, Yongzhi Buijs, Ned Campagna, Roberto Sartini, Davide Emanuelli, Monica Mateuszuk, Lukasz Kij, Agnieszka Chlopicki, Stefan Escudé Martinez de Castilla, Pol Schiffelers, Raymond Martin, Nathaniel I. |
author_sort | van Haren, Matthijs J. |
collection | PubMed |
description | A recently discovered bisubstrate inhibitor of Nicotinamide N-methyltransferase (NNMT) was found to be highly potent in biochemical assays with a single digit nanomolar IC(50) value but lacking in cellular activity. We, here, report a prodrug strategy designed to translate the observed potent biochemical inhibitory activity of this inhibitor into strong cellular activity. This prodrug strategy relies on the temporary protection of the amine and carboxylic acid moieties of the highly polar amino acid side chain present in the bisubstrate inhibitor. The modification of the carboxylic acid into a range of esters in the absence or presence of a trimethyl-lock (TML) amine protecting group yielded a range of candidate prodrugs. Based on the stability in an aqueous buffer, and the confirmed esterase-dependent conversion to the parent compound, the isopropyl ester was selected as the preferred acid prodrug. The isopropyl ester and isopropyl ester-TML prodrugs exhibit improved cell permeability, which also translates to significantly enhanced cellular activity as established using assays designed to measure the enzymatic activity of NNMT in live cells. |
format | Online Article Text |
id | pubmed-8466754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84667542021-09-27 Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity van Haren, Matthijs J. Gao, Yongzhi Buijs, Ned Campagna, Roberto Sartini, Davide Emanuelli, Monica Mateuszuk, Lukasz Kij, Agnieszka Chlopicki, Stefan Escudé Martinez de Castilla, Pol Schiffelers, Raymond Martin, Nathaniel I. Biomolecules Article A recently discovered bisubstrate inhibitor of Nicotinamide N-methyltransferase (NNMT) was found to be highly potent in biochemical assays with a single digit nanomolar IC(50) value but lacking in cellular activity. We, here, report a prodrug strategy designed to translate the observed potent biochemical inhibitory activity of this inhibitor into strong cellular activity. This prodrug strategy relies on the temporary protection of the amine and carboxylic acid moieties of the highly polar amino acid side chain present in the bisubstrate inhibitor. The modification of the carboxylic acid into a range of esters in the absence or presence of a trimethyl-lock (TML) amine protecting group yielded a range of candidate prodrugs. Based on the stability in an aqueous buffer, and the confirmed esterase-dependent conversion to the parent compound, the isopropyl ester was selected as the preferred acid prodrug. The isopropyl ester and isopropyl ester-TML prodrugs exhibit improved cell permeability, which also translates to significantly enhanced cellular activity as established using assays designed to measure the enzymatic activity of NNMT in live cells. MDPI 2021-09-14 /pmc/articles/PMC8466754/ /pubmed/34572571 http://dx.doi.org/10.3390/biom11091357 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article van Haren, Matthijs J. Gao, Yongzhi Buijs, Ned Campagna, Roberto Sartini, Davide Emanuelli, Monica Mateuszuk, Lukasz Kij, Agnieszka Chlopicki, Stefan Escudé Martinez de Castilla, Pol Schiffelers, Raymond Martin, Nathaniel I. Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity |
title | Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity |
title_full | Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity |
title_fullStr | Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity |
title_full_unstemmed | Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity |
title_short | Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity |
title_sort | esterase-sensitive prodrugs of a potent bisubstrate inhibitor of nicotinamide n-methyltransferase (nnmt) display cellular activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466754/ https://www.ncbi.nlm.nih.gov/pubmed/34572571 http://dx.doi.org/10.3390/biom11091357 |
work_keys_str_mv | AT vanharenmatthijsj esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT gaoyongzhi esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT buijsned esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT campagnaroberto esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT sartinidavide esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT emanuellimonica esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT mateuszuklukasz esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT kijagnieszka esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT chlopickistefan esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT escudemartinezdecastillapol esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT schiffelersraymond esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity AT martinnathanieli esterasesensitiveprodrugsofapotentbisubstrateinhibitorofnicotinamidenmethyltransferasennmtdisplaycellularactivity |